Laurus Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is HYDROCHLOROTHIAZIDE USP, with a corresponding US DMF Number 41889.
Remarkably, this DMF maintains an Active status since its submission on August 22, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 06, 2025, and payment made on September 23, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II